Menicon (7780) Fundamentals 2026 — P/E 21.0x, Revenue Analysis | SniperIQ
Menicon (7780) is a JP-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥123.5B, trading at ¥1664.00 on the JPX. This SniperIQ fundamentals page covers Menicon's valuation (P/E 21.0x, P/B 1.4x), profitability (net margin 4.7%), revenue (¥125.6B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Menicon's market cap?
Menicon (7780) has a market capitalization of approximately ¥123.5B, trading at ¥1664.00 on the JPX. Market cap moves with the live share price.
What is Menicon's P/E ratio?
Menicon's trailing twelve-month P/E ratio is 21.0x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Menicon?
Menicon runs a net profit margin of 4.7%, a gross margin of 53.8%, and an operating margin of 8.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Menicon generate?
Menicon reported revenue of ¥125.6B for fiscal year 2025, with net income of ¥5.9B and earnings per share (EPS) of 79.11. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Menicon pay a dividend?
Menicon offers a trailing dividend yield of about 1.7%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Menicon financially healthy?
Menicon carries a debt-to-equity ratio of 0.78x and a current ratio of 2.70x, with a market beta of 0.63. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Menicon a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Menicon (7780) the key facts are: market cap ¥123.5B, P/E 21.0x, revenue ¥125.6B, 52-week range 1090-1929. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Menicon's full fundamentals live
Get Menicon's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.